Your browser doesn't support javascript.
loading
Immune checkpoint inhibitors rechallenge in urological tumors: An extensive review of the literature.
Bimbatti, Davide; Maruzzo, Marco; Pierantoni, Francesco; Diminutto, Alberto; Dionese, Michele; Deppieri, Filippo M; Lai, Eleonora; Zagonel, Vittorina; Basso, Umberto.
Afiliación
  • Bimbatti D; Oncology Unit 1, Department of Oncology, Istituto Oncologico Veneto IOV - IRCCS, Padua, Italy. Electronic address: davide.bimbatti@iov.veneto.it.
  • Maruzzo M; Oncology Unit 1, Department of Oncology, Istituto Oncologico Veneto IOV - IRCCS, Padua, Italy.
  • Pierantoni F; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
  • Diminutto A; Urology Clinic, Department of Surgery, Dentistry, Paediatrics and Gynaecology, University of Verona, Verona, Italy.
  • Dionese M; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
  • Deppieri FM; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
  • Lai E; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
  • Zagonel V; Oncology Unit 1, Department of Oncology, Istituto Oncologico Veneto IOV - IRCCS, Padua, Italy.
  • Basso U; Oncology Unit 1, Department of Oncology, Istituto Oncologico Veneto IOV - IRCCS, Padua, Italy.
Crit Rev Oncol Hematol ; 170: 103579, 2022 Feb.
Article en En | MEDLINE | ID: mdl-35007699
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Urogenitales / Neoplasias Urológicas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Crit Rev Oncol Hematol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Urogenitales / Neoplasias Urológicas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Crit Rev Oncol Hematol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article